| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.11 | 9e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | SNX-2112 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.084 | 0.003 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.006 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.007 |